John L. Villano

10.3k citations
141 papers · 5.0k indexed · 3 hit papers · h-index 34
Topics
Glioma Diagnosis and Treatment (71 papers)Brain Metastases and Treatment (36 papers)Meningioma and schwannoma management (16 papers)
Partner nations
United StatesCanadaSpain

In The Last Decade

John L. Villano

136 papers receiving 4.9k citations

Hit Papers

Epidemiologic and Molecular Prognostic Review of Glioblas...2011202620162021201420112022250500750

Peers

John L. Villano
Comparison fields: 5 of 142
  • Genetics 2.6k
  • Pulmonary and Respiratory Medicine 1.2k
  • Molecular Biology 1.1k
  • Neurology 1.1k
  • Epidemiology 869
Replace Fábio M. Iwamoto with:
Fábio M. Iwamoto United States
Jan Drappatz United States
Andrew D. Norden United States
Maryam Fouladi United States
Yoshitaka Narita Japan
Alberto Broniscer United States
Richard G. Grundy United Kingdom
Chitra Sarkar India
Mathilde C.M. Kouwenhoven Netherlands
Toshihiro Kumabe Japan
John L. Villano relative to Fábio M. Iwamoto United States Fábio M. Iwamoto's profile →
Citations per field
00.5×1.5×2.0×
Fábio M. Iwamoto · 1×
Citations per year

Countries citing papers authored by John L. Villano

Since Specialization
Citations

This map shows the geographic impact of John L. Villano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Villano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Villano more than expected).

Fields of papers citing papers by John L. Villano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John L. Villano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Villano. The network helps show where John L. Villano may publish in the future.

Co-authorship network of co-authors of John L. Villano

This figure shows the co-authorship network connecting the top 25 collaborators of John L. Villano. A scholar is included among the top collaborators of John L. Villano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John L. Villano. John L. Villano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 1
5 3
6 5
7 21
8
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastomabreakdown →
104
9 18
10 0
11 16
12 18
13 11
14 10
15 9
16 47
17 8
18 3
19 3
20 89

About John L. Villano

John L. Villano is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology, having authored 141 papers that have together received 5.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (71 papers), Brain Metastases and Treatment (36 papers) and Meningioma and schwannoma management (16 papers). The work is most often cited by research in Genetics (2.6k citations), Neurology (1.1k citations) and Cancer Research (623 citations). John L. Villano has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Therese A. Dolecek, Bridget J. McCarthy, Jigisha P. Thakkar, Donita Lightner, Craig Horbinski, Quinn T. Ostrom, Jill S. Barnholtz‐Sloan, Matthew Koshy, Linda R. Bressler and Habib Shaikh. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026